Board Member

Eric has over 25 years of financial leadership experience in the pharmaceutical industry, the last 17 years in pharmaceutical contract developing and manufacturing. Most recently he was CFO of Alcami Corporation, retiring after the successful sale of that company. He was also CFO and co-founder of TriPharm Services. Previously, Eric was CFO of Avista Pharma Solutions, where he played a key leadership role the company’s expansion and sale. Eric was also previously CFO of Mayne Pharma US, a publicly-traded company operating in the generic, brand and CDMO pharmaceutical industries, and private equity-backed AAIPharma Services, where he supported a successful expansion strategy.

Other prior pharmaceutical leadership roles include CFO of Patheon Inc., a major publicly-traded, private equity-backed CDMO at the time, and various senior finance roles with Novartis, including CFO of Sandoz Pharmaceuticals, Vice President and Controller of Novartis Pharmaceuticals and Vice President Finance of Novartis Pharmaceuticals.

He holds an MBA from Case Western Reserve University, an MA from the University of Western Ontario and a BA from Queen’s University in Kingston, Ontario.